Sintx Technologies, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Sintx Technologies, Inc. (SINT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $19267.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $97196800.00.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $139237.86.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2019-03-31 was $7423.20.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2017-03-31 was $4638.60, a 19091.56% increase year-over-year.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $17540.00, a 100.00% decline from fiscal 2024.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $891768343.00.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2021 was $139158.00.
- Sintx Technologies, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2018 was $7423.20, a 14.87% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19267.00 10-Q · filed 2026-08-11 | |||||||
| 2025-12-31 | $17540.00 10-K · filed 2026-03-20 | |||||||
| 2025-09-30 | $19267.00 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | $19267.00 10-Q · filed 2026-08-11 | |||||||
| 2025-03-31 | $97196800.00 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | $891768343.00 10-K · filed 2026-03-20 | |||||||
| 2024-09-30 | $891768343.00 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | $891768343.00 10-Q · filed 2025-08-14 | |||||||
| 2022-09-30 | $139237.86 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | $139237.86 10-Q · filed 2022-08-12 | |||||||
| 2022-03-31 | $139237.86 10-Q · filed 2022-05-13 | |||||||
| 2021-12-31 | $139158.00 10-K · filed 2022-03-25 | |||||||
| 2019-03-31 | $7423.20 10-Q · filed 2019-05-16 | |||||||
| 2018-12-31 | $7423.20 10-K · filed 2019-03-11 | |||||||
| 2017-12-31 | $8719.64 10-K · filed 2019-03-11 | |||||||
| 2017-09-30 | $9187.80 10-Q/A · filed 2017-12-29 | $63.78 10-Q · filed 2017-11-16 | ||||||
| 2017-06-30 | $9184.80 10-Q/A · filed 2017-12-29 | $765.40 10-Q · filed 2017-10-31 | ||||||
| 2017-03-31 | $4638.60 10-Q/A · filed 2017-12-29 | $386.55 10-Q · filed 2017-10-31 | ||||||
| 2016-12-31 | $495.96 10-K · filed 2018-03-29 | $41.33 10-K · filed 2017-09-20 | ||||||
| 2016-09-30 | $290.64 10-Q/A · filed 2017-12-27 | $24.22 10-Q · filed 2016-11-14 | ||||||
| 2016-06-30 | $24.17 10-Q · filed 2016-08-12 | |||||||
| 2016-03-31 | $24.17 10-Q · filed 2016-05-13 | |||||||
| 2015-12-31 | $763.80 10-K/A · filed 2017-12-27 | $43.65 10-K · filed 2016-03-23 | ||||||
| 2015-09-30 | $2.88 10-Q · filed 2015-11-16 | |||||||
| 2015-06-30 | $2.86 10-Q · filed 2015-08-14 | |||||||
| 2015-03-31 | $3.06 10-Q · filed 2015-05-08 | |||||||
| 2014-12-31 | $10.54 10-K · filed 2015-03-24 | |||||||
| 2014-09-30 | $8.57 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |